Choline and Geranate Deep Eutectic Solvent as a Broad-Spectrum Antiseptic Agent for Preventive and Therapeutic Applications

Advanced Healthcare Materials

Volumn 5, Issue 11, 2016, Pages 1282-1289

  Zakrewsky, Michael ^a   Banerjee, Amrita ^a   Apte, Sanjana ^a   Kern, Theresa L ^b   Jones, Mattie R ^c   Sesto, Rico E Del ^c   Koppisch, Andrew T ^d   Fox, David T ^b   Mitragotri, Samir ^a  

^a University of California   (United States)

^b LOS ALAMOS NATIONAL LABORATORY   (United States)

^c DIXIE STATE UNIVERSITY   (United States)

^d NORTHERN ARIZONA UNIVERSITY   (United States)

Author keywords

antimicrobial resistance; antiseptics; beacterial infections; drug delivery; infection prevention

Indexed keywords

ANTIINFECTIVE AGENT; CARBAPENEM; CEFALEXIN; CHOLINE; CIPROFLOXACIN; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; ETHIONAMIDE; GERANIC ACID; HAND SANITIZER; ISONIAZID; MACROLIDE; METICILLIN; PSEUDOMONIC ACID; RIFAMPICIN; SOLVENT; UNCLASSIFIED DRUG; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ACNE VULGARIS; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BIOCOMPATIBILITY; CANDIDA ALBICANS; CHEMICAL COMPOSITION; CONDUCTANCE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; HERPES SIMPLEX VIRUS; KERATINOCYTE; LIPOPHILICITY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; PSEUDOMONAS AERUGINOSA; SKIN PENETRATION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS PYOGENES; SYNTHESIS;

EID: 84976589659     PISSN: 21922640     EISSN: 21922659     Source Type: Journal    
DOI: 10.1002/adhm.201600086     Document Type: Article

References (38)

1. I. N. Okeke, R. Laxminarayan, Z. A. Bhutta, A. G. Duse, P. Jenkins, T. F. O'Brien, A. Pablos-Mendez, K. P. Klugman, Lancet Infect. Dis. 2005, 5, 481.
2. FDA, Safety and Effectiveness for Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use; Proposed Amendment of the Tentative Final Monograph; Reopening of Administrative Record. Docket No. FDA-2015-N-0101 (May 20, 2015).
3. WHO, Antimicrobial Resistance: Global Report on Surveillance 2014, Vol. 1 (April, 2014).
4. CDC, ANTIBIOTIC RESISTANCE THREATS in the United States (2013).
5. D. Landman, E. Babu, N. Shah, P. Kelly, O. Olawole, M. Backer, S. Bratu, J. Quale, J. Antimicrob. Chemother. 2012, 67,1427.
6. J. I. Ross, A. M. Snelling, E. Carnegie, P. Coates, W. J. Cunliffe, V. Bettoli, G. Tosti, A. Katsambas, J. Del Pulgar, O. Rollman, L. Torok, E. A. Eady, J. H. Cove, Br. J. Dermatol. 2003, 148,467.
7. B. Bouchrif, B. Paglietti, M. Murgia, A. Piana, N. Cohen, M. M. Ennaji, S. Rubino, M. Timinouni, J. Infect. Dev. Countries 2009, 3, 35.
8. D. Greenberg, N. Buznach, R. Dagan, presented at 42nd ICAAC, September, 2002.
9. A. R. Manges, J. R. Johnson, B. Foxman, T. T. O'Bryan, K. E. Fullerton, L. W. Riley, N. Engl. J. Med. 2001, 345, 1007.
10. Q. H. Zhang, K. D. Vigier, S. Royer, F. Jerome, Chem. Soc. Rev. 2012, 41, 7108.
11. M. Zakrewsky, K. S. Lovejoy, T. L. Kern, T. E. Miller, V. Le, A. Nagy, A. M. Goumas, R. S. Iyer, R. E. Del Sesto, A. T. Koppisch, D. T. Fox, S. Mitragotri, Proc. Natl. Acad. Sci. USA, 2014, 111, 13313.
12. T. Bjarnsholt, K. Kirketerp-Moller, P. O. Jensen, K. G. Madsen, R. Phipps, K. Krogfelt, N. Hoiby, M. Givskov, Wound Repair Regeneration 2008, 16, 2.
13. T. S. Murray, M. Egan, B. I. Kazmierczak, Curr. Opin. Pediatr. 2007, 19, 83.
14. A. Y. Peleg, H. Seifert, D. L. Paterson, Clin. Microbiol. Rev. 2008, 21, 538.
15. N. R. Gandhi, P. Nunn, K. Dheda, H. S. Schaaf, M. Zignol, D. van Soolingen, P. Jensen, J. Bayona, Lancet 2010, 375, 1830.
16. R. A. Bojar, K. T. Holland, Clin. Dermatol. 2004, 22, 375.
17. B. Britton, R. Hervey, K. Kasten, S. Gregg, T. McDonald, Ophthalmic Surg. 1976, 7, 46.
18. J. P. Campbell, F. Plaat, M. R. Checketts, D. Bogod, S. Tighe, A. Moriarty, R. Koerner, Anaesthesia 2014, 69, 1279.
19. P. M. Vogt, K. Reimer, J. Hauser, O. Rossbach, H. U. Steinau, B. Bosse, S. Muller, T. Schmidt, W. Fleischer, Burns 2006, 32, 698.
20. Z. O. Tunay, O. Ozdemir, I. S. Petricli, Cutaneous Ocul. Toxicol. 2015, 34, 12.
21. M. J. Anderson, M. L. David, M. Scholz, S. J. Bull, D. Morse, M. Hulse-Stevens, M. L. Peterson, Antimicrob. Agents Chemother. 2015, 59, 2765.
22. I. R. Sanchez, K. E. Nusbaum, S. F. Swaim, A. S. Hale, R. A. Henderson, J. A. McGuire, Veterinary Surg. 1988, 17,182.
23. A. Desbois, V. Smith, Appl. Microbiol. Biotechnol. 2010, 85,1629.
24. G. McDonnell, A. D. Russell, Clin. Microbiol. Rev. 1999, 12, 147.
25. R. F. Epand, P. B. Savage, R. M. Epand, Biochim. et Biophys. Acta 2007, 1768, 2500.
26. K. M. Whitney, C. M. Ditre, Clin., Cosmet. Invest. Dermatol. 2011, 4, 41.
27. E. A. Grice, J. A. Segre, Nat. Rev. Microbiol. 2011, 9, 244.
28. A. Bialecka, M. Mak, R. Biedron, M. Bobek, A. Kaprowicz, J. Marcinkiewicz, Arch. Immunol. Ther. Exp. 2005, 53, 79.
29. L. A. Doughty, K. B. Nguyen, J. E. Durbin, C. A. Biron, J. Immunol. 2001, 166, 2658.
30. Y. Kano, M. Inaoka, T. Shiohara, Dermatology 2001, 203, 217.
31. D. R. P. Guay, Expert Opin. Pharmacother. 2007, 8, 2625.
32. R. L. Bronaugh, R. F. Stewart, E. R. Congdon, Toxicol. Appl. Pharmacol. 1982, 62, 481.
33. L. M. Deyoung, J. M. Young, S. J. Ballaron, D. A. Spires, S. M. Puhvel, J. Invest. Dermatol. 1984, 83, 394.
34. T. Nakatsuji, M. C. Kao, J. Fang, C. C. Zouboulis, L. Zhang, R. L. Gallo, C. Huang, J. Invest. Dermatol. 2009, 129, 2480.
35. P. Karande, A. Jain, S. Mitragotri, Nat. Biotechnol. 2004, 22,192.
36. Benzalkonium Chloride Wipes Material Safety Data Sheet, Medline Inc.
37. ChloraPrep user manual, CareFusion (2014).
38. Drug Facts, FirstAidOnly Povidone-Iodine Infection Control Wipes.